Healthcare Triangle Signs Letter of Intent to Pursue the Proposed Acquisition of Roboticom's Cutting-Edge Industrial Precision Robotics Automation Business

The proposed acquisition of Roboticom would expand HCTI into industrial robotics and precision automation; Roboticom management's five-year forward-looking projections target $153.5 million in revenue and $64 million in adjusted operating contribution by fiscal year 2029/30; the projections were provided by Roboticom management, are unaudited and unverified by HCTI, subject to significant uncertainty, and actual results may differ materially

PLEASANTON, Calif., Sept. 23, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company") today announced it has signed a non-binding Letter of Intent ("LOI") with Crestpoint Capital LLC ("Seller") outlining a proposed transaction in which HCTI would acquire certain intellectual property, trademarks and business assets associated with Roboticom (roboticom.it), a Pisa, Italy-based provider of industrial robotic automation systems for precision surface treatment, marketed under the SandRob™, ORTIS™ and ScultoRob™ product lines and serving aerospace, marine, composites, orthotics and prosthetics, and industrial-tooling customers.

HCTI believes that, if consummated, the proposed acquisition could potentially extend the Company's technology platform beyond healthcare into industrial automation and advanced manufacturing — sectors the Company believes are experiencing significant growth driven in part by AI adoption — while creating an opportunity to combine HCTI's existing artificial intelligence, cloud and data capabilities with Roboticom's established industrial robotics platform.

Roboticom's technology is marketed through its SandRob™, ORTIS™ and ScultoRob™ product lines and serves applications across aerospace, marine, composites, orthotics and prosthetics, automotive, advanced manufacturing and industrial tooling.

Based on unaudited financial information provided by Roboticom's current ownership group, the business generated approximately $14.1 million in revenue and $6.9 million in gross margin and was EBITDA-positive for fiscal year 2025.

Roboticom management's five-year Growth and Operating Plan, prepared solely by Roboticom management, targets the business to reach approximately $153.5 million in revenue and $64 million in adjusted operating contribution by fiscal year 2029/30. "Adjusted operating contribution" is a non-GAAP financial measure that has not been reconciled to the most directly comparable GAAP measure and may not be comparable to similarly titled measures used by other companies. HCTI is not adopting or endorsing these projections, and investors should not place undue reliance on them. The projections are unaudited, have not been independently verified by HCTI, and remain subject to significant assumptions, uncertainties and confirmation through due diligence, actual results may differ materially.

Proposed Transaction Structure
Under the terms outlined in the LOI, HCTI would acquire 100% of the customer contracts, identified intellectual property, trademarks and business assets for total consideration of up to $30 million in cash and equity paid over time.

Management Comment
"I believe this could represent a significant opportunity for HCTI. I am pleased to explore entering the robotics space and the prospect of combining our AI technology with this business to enhance its competitive positioning." — David Ayanoglou, Chief Financial Officer, Healthcare Triangle, Inc.

About Roboticom
According to publicly available information, Roboticom is a brand of Fabrica Machinale Srl, an Epica International company, based in Navacchio di Cascina (Pisa), Italy, with a commercial presence in Landrum, South Carolina. Its robotic automation systems — including the SandRob™, ORTIS™ and ScultoRob™ product lines and ARPP® software — serve aerospace, automotive, solid-surface, orthopedics, sanitary ware, art and design, woodworking and foundry customers. HCTI's due diligence will include confirmation of the Seller's title to the assets described in the LOI. Descriptions of Roboticom and its business in this release are based solely on information provided by and representations made by the Seller, have not been independently verified by HCTI, and are included for informational purposes only.

About Healthcare Triangle, Inc.
Healthcare Triangle, Inc. (Nasdaq: HCTI), based in Pleasanton, California, reinforces healthcare progress through breakthrough technology and extensive industry knowledge and expertise. The Company supports healthcare organizations — including hospitals and health systems, payers, and pharma/life sciences organizations — in their effort to improve health outcomes through better utilization of the data and information technologies they rely on. Healthcare Triangle's Cloud and Data Platform (CaDP), marketed as CloudEz™ and DataEz™, has achieved HITRUST Risk-based, 2-year (r2) Certified status, demonstrating to clients the highest standards for data protection and information security.

Forward-Looking Statements and Safe Harbor Notice
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 concerning the proposed acquisition of intellectual property, trademarks and business assets associated with Roboticom, including statements regarding the anticipated terms, timing, financing and completion of the proposed transaction, Roboticom's historical and projected financial performance, the potential future spin-off or public listing referenced in the LOI, and the anticipated strategic benefits to HCTI. Such forward-looking statements include words such as "proposed," "intend," "anticipate," "target," "believe" and similar expressions. The fiscal year 2025 financial information was provided by Roboticom's current ownership group, and the fiscal year 2029/30 financial projections were prepared solely by Roboticom management; the projections are not adopted or endorsed by HCTI. The financial information is unaudited, and the financial information and projections have not been independently verified by HCTI; they are subject to significant assumptions, risks and uncertainties, and investors should not place undue reliance on the projections. There is no assurance that Roboticom will achieve these historical results on a verified basis or any projected future results, and actual results may differ materially. The LOI is non-binding, and the proposed transaction is subject to significant risks, uncertainties and conditions, including completion of satisfactory due diligence (including confirmation of clear title to the assets to be acquired), completion of an audit of the target's financial statements, HCTI's ability to secure financing, receipt of required approvals, integration risks, compliance with foreign regulatory requirements, and negotiation of definitive agreements. There is no assurance that a definitive agreement will be signed, that the proposed transaction will be completed on the terms described or at all, or that any future spin-off or listing transaction will be pursued or completed. Nothing in this press release constitutes an offer to sell or a solicitation of an offer to buy any securities, nor a representation that Roboticom, the acquired assets, or any successor entity will be listed on Nasdaq, NYSE or any other exchange. Actual results could differ materially from any forward-looking statements as a result of these and other risks, including those described in HCTI's most recent Annual Report on Form 10-K and other filings with the U.S. Securities and Exchange Commission (the "SEC"). The Company's SEC filings are available at www.sec.gov. All forward-looking statements in this press release are qualified by these cautionary statements, and HCTI undertakes no obligation to update any forward-looking statement except as required by law.

Investor Contact
Healthcare Triangle, Inc.
1-800-617-9550
[email protected] 

SOURCE Healthcare Triangle, Inc.